跳至主要内容
临床试验/ACTRN12620000869976
ACTRN12620000869976已完成未知

Management of early breast cancer during the COVID-19 pandemic: Single institution experience

Westmead Hospital0 个研究点目标入组 165 人开始时间: 2020年8月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
165

研究概览

简要总结

This study assessed symptoms of anxiety, depression and fear of COVID-19 in 430 members of the general community and healthcare workers (HCWs) attending for COVID testing in a public hospital clinic (June–September 2020). Participants completed two questionnaires: Anxiety and Depression Scale (HADS) and the Fear of COVID-19 Scale). HCWs made up 35.1% of the sample. This study demonstrated high levels of anxiety and fear of COVID-19 in laypersons attending ambulatory COVID-19 testing, despite a very low likelihood of a subsequent positive result at the time. There is a strong correlation between fear and anxiety with female gender, people with a lower level of education and individuals attending for repeat testing. The overall level of fear in various subgroups was similar to the alarmingly high results found in Europe in the early stage of the COVID-19 pandemic. HCWs had a lower level of anxiety and fear than members of the general community, and depression scores were comparable with the wider population across both groups. This provides some reassurance that, in an Australian setting with low rates of COVID-19, health professionals are experiencing relatively low levels of anxiety and depression symptoms.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • All new cases of early breast cancer presenting to WBCI and discussed through one of the three multidisciplinary cancer teams (MDTs) will be included.

排除标准

  • 1. Cases of advanced (metastatic) breast cancer.
  • 2. Cases of locally recurrent breast cancer.

研究者

发起方
Westmead Hospital

相似试验